Follow US:
UC Riverside-led study shows how variations in SARS-CoV-2 host gene expression can be linked to variations in COVID-19 susceptibility and symptom severity
UC Riverside-led study is the first to show how tofacitinib rescues gut barrier function from overactive immune cells
Dr. Paul Offit, an international expert on vaccines, will give the 2020 Thomas and Salma Haider Biomedical Breakthrough Lecture at UC Riverside
UC Riverside mouse study focused on neurons in the hippocampus
Osmotic therapy device reduces swelling to prevent secondary injuries in rats
UC Riverside-led study identifies mechanism that prevents death of neurons
Adam Godzik has been named the Bruce D. and Nancy B. Varner Presidential Endowed Chair in Cancer Research
Total funding of three grants exceeds $1.2 million
UC Riverside mouse study will identify mechanisms the gene PTPN2 uses to affect gut cells
UC Riverside-led study shows inhibiting two host cell proteases can accomplish the task
Research supported by five-year NIH grant may have relevance for COVID-19 patients
UC Riverside biomedical scientist Marcus Kaul explains
Scientists discover critical protein complex that lets virus hide from immune system
Drugs previously in development for SARS could be effective for COVID-19
NIH grant of $2.2 million could help researchers target two oncogenes, potentially leading to therapies for melanoma, lung cancer, and other tumors
UC Riverside-led study is the first to show how tofacitinib affects epithelial cells lining the gut
UC Riverside-led study tested the effects of microgravity on intestinal epithelial cells
UC Riverside mouse study finds early exposure to sounds can address hypersensitivity to noise associated with Fragile X Syndrome
The shape and architecture of collagen and elastin fibers can improve our understanding of lung diseases, including the one associated with vaping
UC Riverside-led research could aid regenerative stem cell therapies
